{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:36:20Z","timestamp":1771007780219,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T00:00:00Z","timestamp":1440633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.bjorl.2015.08.011","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T01:17:28Z","timestamp":1441675048000},"page":"589-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients"],"prefix":"10.1016","volume":"81","author":[{"given":"Lucia Bencke","family":"Geyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Saldanha","family":"Menna Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liese Loureiro","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriane Ribeiro","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2015.08.011_bib0255","first-page":"228","article-title":"Atenci\u00f3n multidisciplinaria a pacientes con fibrosis qu\u00edstica","volume":"71","author":"Rubio","year":"1999","journal-title":"Rev Cubana Pediatr"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0260","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.clinbiochem.2012.05.034","article-title":"Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy","volume":"45","author":"Lubamba","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0265","series-title":"Pneumologia no consult\u00f3rio","first-page":"279","article-title":"Fibrose C\u00edstica","author":"Dalcin","year":"2009"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0270","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0272-5231(21)00424-X","article-title":"Abnormal respiratory epithelial ion transport in cystic fibrosis","volume":"7","author":"Knowles","year":"1986","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0275","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3476(95)70157-5","article-title":"Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene-mutations","volume":"127","author":"Wilschanski","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0280","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00431-008-0693-2","article-title":"What's new in cystic fibrosis? From treating symptoms to correction of the basic defect","volume":"167","author":"Proesmans","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02961666","article-title":"Aminoglycoside induced ototoxicity in patients with cystic fibrosis","volume":"160","author":"Mulherin","year":"1991","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0290","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archotol.128.2.150","article-title":"Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis","volume":"128","author":"Stavroulaki","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0295","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0165-5876(03)00135-6","article-title":"The prevalence of neurosensorial hearing loss among cystic fibrosis patients from Hospital de Clinicas de Porto Alegre","volume":"67","author":"Piltcher","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0300","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.otohns.2009.03.020","article-title":"Sensorineural hearing loss in patients with cystic fibrosis","volume":"141","author":"Cheng","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0305","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S1808-8694(15)31053-3","article-title":"Auditory monitoring in ototoxicity","volume":"72","author":"Jacob","year":"2006","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0310","first-page":"229","article-title":"Audiological management of patients receiving aminoglycoside antibiotics","volume":"105","author":"Konrad-Martin","year":"2005","journal-title":"Volta Rev"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0315","series-title":"Position statement and clinical practice guidelines","author":"American Academy of Audiology [Internet]","year":"2009"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1044\/jshd.5101.53","article-title":"Effects of mild and moderate hearing impairments on language, education and psychosocial behavior of children","volume":"51","author":"Davis","year":"1986","journal-title":"J Speech Hear Disord"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0196-0709(84)80009-5","article-title":"Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected cases studies","volume":"5","author":"Fausti","year":"1984","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1590\/S1516-80342011000100020","article-title":"Audiometria de altas frequ\u00eancias no diagn\u00f3stico complementar em audiologia: uma revis\u00e3o da literatura nacional","volume":"16","author":"Klagenberg","year":"2011","journal-title":"Rev Soc Bras Fonoaudiol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0335","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","article-title":"High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity","volume":"165","author":"Fausti","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0340","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AAC.31.4.594","article-title":"Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis","volume":"31","author":"Pedersen","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0345","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/archpedi.1989.02150230086028","article-title":"Aminoglycoside ototoxicity in cystic fibrosis","volume":"143","author":"McRorie","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0350","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0355","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.00995-05","article-title":"Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once versus three-times-daily tobramycin in cystic fibrosis patients","volume":"50","author":"Mulheran","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0360","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0188-4409(03)00022-5","article-title":"Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment","volume":"34","author":"Toral-Marti\u00f1\u00f3n","year":"2003","journal-title":"Arch Med Res"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0365","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions","volume":"25","author":"Knight","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03005364000000004","article-title":"Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects","volume":"31","author":"Mulheran","year":"1997","journal-title":"Br J Audiol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0375","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0385-8146(96)80023-X","article-title":"Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions","volume":"23","author":"Ozturan","year":"1996","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0380","first-page":"257","article-title":"Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study","volume":"9","author":"Littman","year":"1998","journal-title":"J Am Acad Audiol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0385","first-page":"215","article-title":"Monitoramento da audi\u00e7\u00e3o de pacientes expostos \u00e0 cisplatina","volume":"69","author":"Garcia","year":"2003","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0390","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","article-title":"Factors affecting sensitivity of distortion product otoacoustic emissions to ototoxic hearing loss","volume":"29","author":"Reavis","year":"2008","journal-title":"Ear Hear"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0395","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pbc.24236","article-title":"The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy","volume":"60","author":"Abujamra","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0400","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archotol.1970.04310040005002","article-title":"Clinical experience with impedance audiometry","volume":"92","author":"Jerger","year":"1970","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0405","first-page":"17","article-title":"M\u00e9dia dos limiares tonais na audiometria de alta frequ\u00eancia em indiv\u00edduos normais de 4 a 60 anos","volume":"12","author":"Pedalini","year":"2000","journal-title":"Pr\u00f3-Fono"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0410","first-page":"93","article-title":"Audiometria de alta frequ\u00eancia: estudo com indiv\u00edduos audiologicamente normais","volume":"69","author":"Sahyeb","year":"2003","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0415","first-page":"215","article-title":"Avalia\u00e7\u00e3o dos limiares de audibilidade das altas frequ\u00eancias em indiv\u00edduos entre 18 e 29 sem queixas otol\u00f3gicas","volume":"73","author":"S\u00e1","year":"2007","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0420","first-page":"62","article-title":"Limiares auditivos para altas frequ\u00eancias em adultos sem queixa auditiva","volume":"25","author":"Carvallo","year":"2007","journal-title":"Acta ORL"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0425","series-title":"Conhecimentos essenciais para entender bem emiss\u00f5es otoac\u00fasticas e BERA","first-page":"35","article-title":"Emiss\u00f5es otoac\u00fasticas","author":"Azevedo","year":"2003"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0430","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/014556131109000506","article-title":"The role of ultrahigh-frequency audiometry in the early detection of systemic drug-induced hearing loss","volume":"90","author":"Chauhan","year":"2011","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0435","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/AUD.0b013e318228a77d","article-title":"High-frequency pure-tone audiometry in children: a test\u2013retest reliability study relative ototoxic criteria","volume":"33","author":"Beahan","year":"2012","journal-title":"Ear Hear"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0440","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S0022215100093762","article-title":"A controlled study of reliability of pure tone audiometry for the detection of gentamicin auditory toxicity","volume":"97","author":"Davey","year":"1983","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0445","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1044\/hhd9.1.10","article-title":"Objective measures of ototoxicity","volume":"9","author":"Leigh-Paffenroth","year":"2005","journal-title":"Perspect Hear Hear Disord Res Diagn"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0450","first-page":"264","article-title":"Avalia\u00e7\u00e3o do uso da audiometria em frequ\u00eancias ultra-altas em pacientes submetidos ao uso de otot\u00f3xicos","volume":"50","author":"Weigert","year":"2013","journal-title":"Bras Med"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0455","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijporl.2010.01.021","article-title":"Hearing loss in cystic fibrosis","volume":"74","author":"Martins","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0460","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14992027.2010.524253","article-title":"Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions","volume":"50","author":"Al-Malky","year":"2011","journal-title":"Int J Audiol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0465","first-page":"172","article-title":"Contralateral suppression of distortion product otoacoustic emissions in children with cystic fibrosis: effects of tobramycin","volume":"9","author":"Katbamna","year":"1998","journal-title":"J Am Acad Audiol"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0470","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00003446-199910000-00002","article-title":"Effects of chronic tobramycin treatment on distortion product emissions","volume":"20","author":"Katbamna","year":"1999","journal-title":"Ear Hear"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0475","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archotol.125.2.215","article-title":"High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions","volume":"125","author":"Arnold","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/149.1.23","article-title":"Risk factors for the development of auditory toxicity in patients receiving aminoglycosides","volume":"149","author":"Moore","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0485","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-4274(90)90033-I","article-title":"Aminoglycoside-induced ototoxicity","volume":"52","author":"Govaerts","year":"1990","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0490","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.200109-012CC","article-title":"Aminoglycoside prescribing and surveillance in cystic fibrosis","volume":"167","author":"Tan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0495","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003088-198713040-00002","article-title":"Antibiotic pharmacokinetics in cystic fibrosis differences and clinical significance","volume":"13","author":"de Groot","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bjorl.2015.08.011_bib0500","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02914541","article-title":"Pharmacokinetics of drugs in cystic fibrosis","volume":"9","author":"Spino","year":"1991","journal-title":"Clin Rev Allergy"}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869415001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869415001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:22:33Z","timestamp":1761722553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869415001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1808869415001500"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2015.08.011","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2015.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}